D. Robertson, THE ROLE OF CLINICAL-PHARMACOLOGY IN MOLECULAR-GENETICS, International journal of clinical pharmacology and therapeutics, 35(4), 1997, pp. 135-141
Problem: Discovering the causes of unusual phenotypes in human subject
s is an important aspect of patient-oriented research. Material: The t
ools of clinical pharmacology are uniquely useful in addressing these
problems. Patients, subjects, or case histories: We evaluated a 42-yea
r-old patient with lifelong orthostatic hypotension and ptosis of the
eyelids. He underwent a series of biochemical, physiological, and phar
macological tests outlined in this article, Results: These studies ind
icated that sympathetic innervation was intact but that the sympatheti
c neurotransmitter was dopamine rather than norepinephrine. These resu
lts demonstrated that dopamine-beta-hydroxylase deficiency underlies t
he clinical abnormalities of this patient. Conclusion: In selected ind
ividuals with unusual phenotypes, the techniques of clinical chemistry
and clinical pharmacology can define the nature of the defect at almo
st the resolution of the human genome.